Ekero, Sweden

Rolf Larsson


Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 141(Granted Patents)


Company Filing History:


Years Active: 1978-1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rolf Larsson: Innovator in Surface Modification and Medical Technology

Introduction

Rolf Larsson is a notable inventor based in Ekero, Sweden. He has made significant contributions to the fields of surface modification and medical technology. With a total of 2 patents, his work focuses on innovative methods that enhance the functionality of various substrates and medical articles.

Latest Patents

Rolf Larsson's latest patents include a surface modified solid substrate and a method for its preparation. This invention involves a substrate that carries a complex of a polymeric cationic surfactant and a dialdehyde. The modification allows for the impartation of positive or negative charges to the substrate, utilizing reactive groups in bonded compounds. The preparation process involves contacting the substrate with the surfactant and dialdehyde under specific conditions to form a complex. His second patent is for a non-thrombogenic medical article, which is achieved through a surface coating containing heparin. This heparinized surface is stabilized by a cationic surfactant and a dialdehyde, ensuring its effectiveness in medical applications.

Career Highlights

Throughout his career, Rolf Larsson has worked with several companies, including Ird-Biomaterial AB and Aminkemi Aktiebolag. His experience in these organizations has contributed to his expertise in biomaterials and surface modification technologies.

Collaborations

Rolf has collaborated with notable individuals in his field, including Carl-Gustaf Golander and Jan-Christer Eriksson. These partnerships have likely enriched his research and development efforts.

Conclusion

Rolf Larsson's innovative work in surface modification and medical technology has led to significant advancements in these fields. His patents reflect a commitment to improving the functionality and safety of medical articles and substrates.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…